gambogenic acid, neo-gambogic acid, neogambogic acid

| Name | Gambogenic acid | ||
| PubChem CID | 10794070 | ||
| Molecular Weight | 630.8g/mol | ||
| Synonyms |
gambogenic acid, neo-gambogic acid, neogambogic acid |
||
| Formula | C₃₈H₄₆O₈ | ||
| SMILES | CC(=CCCC(=CCC1=C(C(=C2C(=C1O)C(=O)C3=CC4CC5C3(O2)C(C4=O)(OC5(C)C)CC=C(C)C(=O)O)CC=C(C)C)O)C)C | ||
| InChI | 1S/C38H46O8/c1-20(2)10-9-11-22(5)13-15-25-30(39)26(14-12-21(3)4)33-29(31(25)40)32(41)27-18-24-19-28-36(7,8)46-37(34(24)42,38(27,28)45-33)17-16-23(6)35(43)44/h10,12-13,16,18,24,28,39-40H,9,11,14-15,17,19H2,1-8H3,(H,43,44)/b22-13+,23-16-/t24-,28+,37+,38-/m1/s1 | ||
| InChIKey | RCWNBHCZYXWDOV-VSFMGBBVSA-N | ||
| ChEMBL ID | CHEMBL2205166 | ||
| Structure |
Download
2D
MOL
3D
MOL
|
||
| Chineses Pinyin | TengHuang | ||
| Use Part | Balsam | ||
| Habitat | India , Thailand , India | ||
| Flavor | Sour, Astringent | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Malpighiales
-->Family: Clusiaceae
-->Genus: Garcinia
-->Species: Garcinia hanburyi
|
||
| Pair Name | Gambogenic acid, Doxorubicin | |||
| Partner Name | Doxorubicin | |||
| Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
| Biological Phenomena | Induction-->Autophagy | |||
| Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
| Down-regulation | Expression | BCL2 | hsa596 | |
| Up-regulation | Expression | MAP1LC3A | hsa84557 | |
| Down-regulation | Expression | MAP1LC3B | hsa81631 | |
| Up-regulation | Expression | BECN1 | hsa8678 | |
| Up-regulation | Expression | SQSTM1 | hsa8878 | |
| In Vitro Model | BEL-7402 | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_5492 |
| Result | Gambogenic Acid Inhibits Basal Autophagy of Drug-Resistant Hepatoma Cells and Improves Its Sensitivity to Adriamycin. | |||
| Pair Name | Gambogenic acid, Erlotinib | |||
| Partner Name | Erlotinib | |||
| Disease Info | [ICD-11: 2C25.Z] | Lung cancer | Investigative | |
| Gene Regulation | Down-regulation | Phosphorylation | FRS2 | hsa10818 |
| Down-regulation | Phosphorylation | MAPK1 | hsa5594 | |
| Down-regulation | Phosphorylation | RPS6 | hsa6194 | |
| Down-regulation | Phosphorylation | FGFR3 | hsa2261 | |
| Down-regulation | Phosphorylation | AKT1 | hsa207 | |
| Down-regulation | Phosphorylation | EGFR | hsa1956 | |
| In Vitro Model | HCC827 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_2063 |
| HCC827 ER1 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_EJ07 | |
| NCI-H1650 | Minimally invasive lung adenocarcinoma | Homo sapiens (Human) | CVCL_1483 | |
| In Vivo Model | The human cell-derived tumor xenografts (CDX) were established by s.c. injecting 0.2 ml of the tumor cell suspension (1×10⁷ cells) mixed 1:1 with Matrigel (Becton Dickinson). | |||
| Result | Our findings provide preclinical evidence for using GNA as an FGFR signaling pathway inhibitor to overcome erlotinib resistance in NSCLC treatment or to enhance erlotinib efficacy when used as a combined administration. | |||
| Pair Name | Gambogenic acid, Fluorouracil | |||
| Partner Name | Fluorouracil | |||
| Disease Info | [ICD-11: 2C25.Z] | Lung cancer | Investigative | |
| Biological Phenomena | Induction-->Necroptosis | |||
| Gene Regulation | Up-regulation | Expression | CASP9 | hsa842 |
| Up-regulation | Expression | CASP3 | hsa836 | |
| Up-regulation | Expression | BAX | hsa581 | |
| Up-regulation | Expression | RIPK1 | hsa8737 | |
| Up-regulation | Expression | AIFM1 | hsa9131 | |
| Up-regulation | Expression | CYCS | hsa54205 | |
| Up-regulation | Expression | PPID | hsa5481 | |
| Down-regulation | Expression | BCL2 | hsa596 | |
| In Vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 |
| Result | These mechanisms may be due to the toxicity of targeted toxin to mitochondria via the mitochondrial pathway. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Gambogenic Acid Inhibits Basal Autophagy of Drug-Resistant Hepatoma Cells and Improves Its Sensitivity to Adriamycin. Biol Pharm Bull. 2022;45(1):63-70. doi: 10.1248/bpb.b21-00511. | Click |
| 2 | Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth. Cell Death Dis. 2018 Feb 15;9(3):262. doi: 10.1038/s41419-018-0314-6. | Click |
| 3 | Synergistic effects of 5-fluorouracil and gambogenic acid on A549 cells: activation of cell death caused by apoptotic and necroptotic mechanisms via the ROS-mitochondria pathway. Biol Pharm Bull. 2014;37(8):1259-68. doi: 10.1248/bpb.b13-00972. | Click |